TALEN-HPV16 E6/E7

Developed for: human papilloma virus infection
Investigated by: First Affiliated Hospital, Sun Yat-Sen University · Jingchu University of Technology

today NCT03057912 · Ph 1

2018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03057912	Jan → Nov 2018	human papilloma virus infection	First Affiliated Hospital, Sun Yat-Sen University	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	TALEN-HPV16 E6/E7	“TALEN-HPV16 E6/E7;TALEN-HPV18 E6/E7” NCT03057912 ↗
Action	Inhibit	“could produce disruption of HPV16 and HPV18 E6/E7 DNA, significantly decreasing the expression of E6/E7” NCT03057912 ↗